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Loss of UBE3A from TH-expressing neurons
suppresses GABA co-release and enhances
VTA-NAc optical self-stimulation
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Motivated reward-seeking behaviours are governed by dopaminergic ventral tegmental area
projections to the nucleus accumbens. In addition to dopamine, these mesoaccumbal
terminals co-release other neurotransmitters including glutamate and GABA, whose roles in
regulating motivated behaviours are currently being investigated. Here we demonstrate that
loss of the E3-ubiquitin ligase, UBE3A, from tyrosine hydroxylase-expressing neurons impairs
mesoaccumbal, non-canonical GABA co-release and enhances reward-seeking behaviour
measured by optical self-stimulation.
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D
opamine projections from the ventral tegmental area
(VTA) target the nucleus accumbens (NAc) and release
dopamine in response to reward-predictive cues, which in
turn initiates reward-seeking and promotes reward learning1–3.
While phasic dopamine dynamics have been well-characterized
within the NAc1, dopaminergic terminals are now known to be
capable of co-releasing several neurotransmitters including
gamma-aminobutyric acid (GABA) and glutamate4–7. However,
the role of mesoaccumbal non-canonical GABA and glutamate
co-release remains to be elucidated.
The mechanisms differ for glutamate and GABA co-release,
presenting an opportunity to dissect their functional roles.
Glutamate co-release in the mesoaccumbal pathway occurs in
restricted axonal microdomains and is not necessarily packaged
within the same synaptic vesicles as dopamine7. Conversely,
GABA co-release requires the vesicular monoamine transporter-2
(VMAT2), which is also required for dopamine vesicular loading,
suggesting that GABA and dopamine can be packaged within
the same synaptic vesicles at mesoaccumabal terminals5.
Dopaminergic neurons do not express conventional GABA
synthesizing enzymes, but instead actively uptake ambient
GABA in their terminals within the NAc, a process mediated
by GABA transporter-1 (GAT1)5,8.
Here, we describe our efforts to optogenetically dissect the
underlying causes of disrupted reward-seeking behaviours in
mice that lack the maternal copy of Ube3a, a mouse model
for Angelman syndrome (Ube3am /pþ ). In doing so, we
serendipitously discovered that the loss of the E3-ubiquitin
ligase, Ube3a, did not directly alter VTA-to-NAc dopamine
release but is essential for GABA co-release and the modulation
of positively reinforced behaviour. Our findings reveal a
novel molecular mechanism underlying GABA co-release from
mesoaccumbal terminals and provide new insights into the
relevance of this non-canonical mode of neurotransmission to
motivated behaviour.
Results
Mesoaccumbal optical stimulation in a Ube3a-null model. In
an effort originally designed to elucidate mechanisms underlying
dopaminergic dysfunction in an Angelman syndrome mouse
model9, we used a reductionist approach to selectively manipulate
the mesoaccumbal dopaminergic pathway. To target
catecholaminergic neurons, mice expressing CRE recombinase
within THþ neurons (THCRE) were crossed into Ube3am /pþ
mice or their wild-type littermates (Ube3amþ /pþ ). To specifically
manipulate the axon terminals of NAc-projecting THþ neurons,
we transduced CRE-dependent AAV5-channelrhodopsin-2
(H134R) fused to enhanced yellow fluorescent protein
(ChR2-eYFP) into the VTA and implanted an optical fibre
above the NAc (Fig. 1a). We observed qualitatively similar viral
expression within Ube3a-deficient lines compared with their
wild-type littermates (Fig. 1b and Supplementary Fig. 1), but
observed no expression following viral injection into
CRE-negative control mice. To determine if there are
differences in positive-reinforcement behaviour, we trained
THCRE::Ube3am /pþ and THCRE::Ube3amþ /pþ mice to nose-
poke for optical stimulation with a fixed-ratio one schedule of
reinforcement. We used a 30Hz optical-stimulation paradigm, as
this stimulation frequency is within a range previously shown to
produce robust DA release at NAc terminals, and has been used
across various behavioural paradigms examining the effects of
neuromodulatory release in vivo10–14. THCRE::Ube3am /pþ and
THCRE::Ube3amþ /pþ mice similarly learned an appetitive
nose-poke operant task (Supplementary Fig. 2) for natural
rewards. However, THCRE::Ube3am /pþ mice nose-poked to
receive optical stimulation significantly more than
THCRE::Ube3amþ /pþ mice (Fig. 1c,d). These data suggest that
the loss of UBE3A enhances motivation driven through THþ
terminals within the NAc, thus increasing optical self-stimulation.
Motivation and dopaminergic physiology in Ube3am /pþ mice.
On the basis of previous findings9, we hypothesized that UBE3A
loss might enhance optically evoked reward-seeking by increasing
VTA-to-NAc dopamine release. To examine this possibility, we
performed in vitro fast-scan cyclic voltammetry in brain slices
from THCRE::Ube3am /pþ and THCRE::Ube3amþ /pþ mice
expressing ChR2-eYFP within VTA-to-NAc terminals. To probe
for possible changes in dopamine release, we optically stimulated
either with a single pulse (Fig. 2b) or with stimulation trains across
a range of frequencies (Fig. 2c). Contrary to our initial hypothesis,
the loss of UBE3A had no effect on dopamine availability or
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Figure 1 | Ube3am /pþ mice are hyper-motivated to self-stimulate TH-positive VTA-to-NAc terminals. (a) Schematic representation of DIO-ChR2-
eYFP viral transduction within the VTA along with NAc chronic fibre placements into THCRE-positive mice. (b) Immunohistochemistry of ChR2-eYFP
(green), and DAPI (blue) in a THCRE::Ube3am /pþ mouse. Scale bar, 500mm. (c) Cumulative response plots showing nose pokes that trigger a 30Hz,
473 nm stimulus (active nose pokes) in representative mice. (d) Average number of nose pokes for triggering (active nose pokes) or not triggering
(inactive) 30Hz optical stimulation across a 60-min session. THCRE::Ube3am /pþ mice were significantly more motivated to trigger optical stimulation
than THCRE::Ube3amþ /pþ mice (n¼ 7/group, one-way ANOVA, *Po0.05). All bars represent the mean±s.e.m.
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release. Moreover, using in vitro whole-cell electrophysiology, we
found that intrinsic excitability and inhibition onto VTA THCREþ
neurons were unchanged in THCRE::Ube3am /pþ mice compared
with controls (Fig. 3). Collectively, these findings suggest that
enhanced reward seeking in Ube3am /pþ mice is not due to
changes in dopamine release from VTA-to-NAc dopaminergic
terminals or due to altered excitability of dopaminergic VTA
neurons in Ube3am /pþ mice.
Consequences of selective Ube3a deletion in THþ neurons.
Because VTA neurons exhibited typical excitability and retain a
normal capacity to release dopamine in Ube3am /pþ mice (Figs 2
and 3), we questioned if maternal Ube3a deletion selectively in
catecholaminergic neurons would be sufficient to alter motiva-
tional drive. To test this, we used a novel conditional Ube3a
knockout mouse (Ube3aFLOX/pþ ) to selectively delete maternal
Ube3a in a THCRE-dependent manner (Supplementary Figs 1 and
3a). We injected THCRE::Ube3aFLOX/pþ and THCRE::Ube3amþ /pþ
mice with CRE-dependent ChR2-eYFP into the VTA to determine
if deletion of Ube3a within THþ neurons would be sufficient to
phenocopy self-stimulation phenotypes observed in AS model
mice. Mice were trained to nose-poke (as described above) for
optical stimulation of CREþ terminals within the NAc.
THCRE::Ube3aFLOX/pþ mice poked significantly more for 30Hz
stimulation than THCRE::Ube3amþ /pþ mice (Fig. 4a). This dif-
ference occurred in the absence of observable changes in optically
evoked dopamine release (Fig. 4b,c). These data demonstrate that
the selective loss of UBE3A in THþ neurons is sufficient to
enhance motivational drive despite the lack of a detectable deficit
in NAc dopamine release.
Dopaminergic terminals in the NAc are also capable of
releasing glutamate and GABA5–7,15. Thus, we tested whether
Ube3a loss in THþ neurons could alter transmitter co-release. To
assess this, we first optogenetically activated VTA-to-NAc
terminals and measured GABAergic currents in ventral striatal
medium spiny neurons while blocking glutamatergic responses
with AMPA and NMDA receptor antagonists (Fig. 4d). We
applied a single light-pulse (20ms) to measure peak amplitude
and the kinetics of the resulting current by averaging Z6
consecutive traces (Fig. 4e). We confirmed post hoc that these
currents were GABAR-mediated by bath applying SR95531
(10 mM), a selective GABA-A receptor antagonist (Fig. 4e). To
verify that these GABAergic currents were a consequence of
co-release rather than release by GAD1þ /TH neurons
spuriously expressing ChR2 due to non-specific CRE expression
in the THCRE line, we treated mice with the VMAT2 inhibitor,
reserpine, thereby selectively inhibiting vesicular loading in
dopaminergic terminals capable of co-release. Similar to
previous electrophysiological studies15 and our own anatomical
evidence showing that the vast majority of ChR2-expressing
neurons in the VTA are THþ (Supplementary Fig. 4a,b), we
found that reserpine abolished nearly all optically evoked
GABAergic currents in the NAc (Supplementary Fig. 4c). This
further demonstrates that our optical stimulation almost
exclusively evoked GABA release from dopaminergic terminals.
Despite exhibiting normal glutamatergic co-release with optical
stimulation of VTA-to-NAc terminals (Supplementary Fig. 5a,b),
THCRE::Ube3aFLOX/pþ mice showed a 450% reduction in peak
amplitude of GABAergic currents relative to controls, while
current decay kinetics proved normal (Fig. 4e–g). Using an
optical-stimulation paradigm similar to that used in the
behavioural experiments, we also found that THCRE::Ube3a-
FLOX/pþ mice exhibit diminished GABAergic currents at 30Hz
stimulation of VTA-to-NAc terminals compared with control
mice (Fig. 4h).
Exogenous VGAT reverses UBE3A-deficient phenotypes. We
tested if GABA co-release could be restored in THCRE::
Ube3aFLOX/pþ mice, and whether this could normalize
motivational drive. The observed decrease in GABA co-release
could arise from changes in GABA uptake, availability, release or
vesicular loading5,15,16. To enhance vesicular loading of GABA in
THþ terminals, we used a CRE-dependent virus expressing the
vesicular GABA transporter (VGAT) and introduced this with
DIO-ChR2-eYFP at a 1:1 ratio within the VTA (Fig. 5a)15. GABA
co-release evoked by a single light-pulse or a 30Hz optical
stimulation was similar in THCRE::Ube3aFLOX/pþ ::DIO-VGAT mice
compared with THCRE::Ube3amþ /pþ ::DIO-VGAT mice (Fig. 5b–d,
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Figure 2 | Optically evoked dopamine release is similar in TH-positive VTA-to-NAc terminals in Ube3am /pþ and Ube3amþ /pþ mice. (a)
Representative fast-scan voltammetric recordings from ventral striatal slices in both THCRE::Ube3am /pþ and THCRE::Ube3amþ /pþ mice. Insets represent
background-subtracted electrochemical signal characteristic of oxidized dopamine. Right: consecutive background-subtracted voltammogram recorded
over an 8-s interval. Applied electrode potential (Eapps versus Ag/AgCl reference electrode) is shown versus time. (b) Light-evoked current is similar in
both genotypes at 1 pulse (Student’s t-test, P¼0.99, n¼8, 9) and (c) across a range of frequencies (one-way ANOVA, P¼0.83, n¼ 11, 12).
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P40.05). Exogenous expression of VGAT within THþ terminals
was also sufficient to normalize optical intracranial self-
stimulation responding in THCRE::Ube3aFLOX/pþ ::DIO-VGAT
mice compared with THCRE::Ube3amþ /pþ ::DIO-VGAT mice
(Fig. 5e,f), suggesting a causal relationship between
the observed deficits in GABA co-release and alterations
in motivational drive in the absence of UBE3A (Fig. 5f,
P40.05).
Discussion
In this study we optogenetically dissected mesoaccumbal circuitry
to investigate the underlying causes of disrupted reward-seeking
behaviours in a Ube3a-deficient mouse model. Collectively, our
data indicate that UBE3A regulates circuits involved in motivated
behaviour and, in particular, GABA co-release from putative
dopaminergic mesoaccumbal terminals. Following UBE3A loss,
suppressed GABA co-release and enhanced optical self-stimula-
tion occur in the absence of other measured cellular and synaptic
deficits in the mesoaccumbal pathway. Remarkably, exogenous
expression of VGAT is sufficient to reinstate GABA co-release
and normalize motivational drive in the UBE3A-deficient circuit,
suggesting a causal link between GABA co-release from VTA-
to-NAc terminals and the modulation of motivation.
We previously concluded, based on electrical stimulation of the
medial forebrain bundle in Ube3am /pþ mice, that the loss of
UBE3A enhances dopamine release at the mesoaccumbal
pathway, thereby reducing reward threshold9. Consequently, we
hypothesized here that selective loss of UBE3A in THþ neurons
would be sufficient to alter dopamine release within the
NAc. Instead, we find that optogenetically evoked release in
VTA-to-NAc terminals is normal (Figs 2b,c and 4b,c). Given that
medial forebrain bundle stimulation is known to activate diverse
circuit pathways17, including septal nuclei, there are numerous
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Figure 3 | Maternal deletion of Ube3a has no apparent effect on intrinsic excitability and inhibitory input onto VTA neurons. (a) Representative traces
and average data showing action potential firing rates to increasing current injections in Ai9-positive VTA neurons in THCRE::Ai9::Ube3am /pþ and
THCRE::Ai9::Ube3amþ /pþ mice (n¼ 18 per group, Student’s t-test, P¼0.70). (b) Average values of resting membrane potential (Student’s t-test, P¼0.46),
membrane resistance (P¼0.25), maximum instantaneous firing frequency (Student’s t-test, P¼0.22), and average action potential peak amplitude
(Student’s t-test, P¼0.32) of Ai9-positive neurons. (c) Representative traces and average data showing the frequency and amplitude of sIPSCs in Ai9-
positive neurons (n¼ 12 for each genotype, Student’s t-test, P¼0.42, P¼0.24). GABAergic currents were validated by bath application of SR95531. All
bars represent mean±s.e.m.
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explanations for our previous observation of enhanced dopamine
release in the NAc of Ube3am /pþ mice9. Regardless, our
new results demonstrate that the loss of UBE3A specifically in
TH-expressing neurons leads to a reduction in GABA
co-release without corresponding reductions in dopamine
release, and that this reduction of GABA co-release is
sufficient to enhance optogenetically mediated, positively
reinforced behaviours. Importantly, GABA co-release may
also regulate natural appetitive behaviours such as copulation,
social interactions and, as shown recently, binge drinking8.
However, sucrose seeking is unaffected in both Ube3am /pþ and
THCRE::Ube3aFLOX/pþ (Supplementary Figs 2 and 5c),
indicating that GABA co-release is not involved in food-
seeking and suggests at least some degree of specificity
for this release mechanism in the modulation of appetitive
behaviour.
While these data provide the first functional role for GABA
co-release within the ventral striatum in an in vivo context, the
utility for GABA co-release regulating motivational drive for
ethologically relevant appetitive stimuli remains to be deter-
mined. Furthermore, we cannot rule out the possibility that our
effect might be driven in part by ectopic CRE expression within
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GABAergic neurons18. However, this possibility seems unlikely
given that we observe a low percentage of ChR2 and GAD1
overlap (B3%), and that we also found that the VMAT2 inhibitor
(reserpine) blocked most of the GABAergic currents. Moreover,
GABAergic VTA-to-NAc projections preferentially synapse on
cholinergic interneurons within the NAc19, further decreasing the
possibility of ectopic CRE expression contributing to our
observed effects.
UBE3A is an E3-ubiquitin ligase that transfers ubiquitin to a
targeted substrate for proteasomal degradation20, thus UBE3A
loss causes an accumulation of targeted UBE3A substrates. Recent
evidence suggests that GAT1 is a potential UBE3A substrate16,
proposing that UBE3A loss could directly alter GAT1 transport
function. While the mechanistic details remain to be established,
our findings support the hypothesis that anomalous GABA
uptake on UBE3A loss not only leads to severely attenuated
GABA co-release, but also augments motivational drive via
mesoaccumbal pathway activation.
Methods
Experimental subjects and stereotaxic surgeries. Cg-Tg-TH:Cre mice (JAX #:
008601), Rosa26-stop-floxed-tdTomato (Ai9, JAX #: 007909) and Ube3a-deficient
(JAX #: 016590) mice were obtained through Jackson Laboratories (Bar Harbor,
ME). Ube3a-floxed mice (Ube3aFLOX) were engineered in conjunction with the
UNC Animal Models Core. Briefly, C57BL/6 mouse embryonic stem cells were
electroporated with an AsiSI-linearized Ube3aKO1st targeting construct, which was
generated by the trans-NIH Knockout Mouse Project (KOMP) and obtained from
the KOMP repository (www.komp.org). To produce Ube3aKO1st-targeted chimeric
mice, Ube3aKO1st-targeted embryonic stem cells were microinjected into
C57BL/6-albino blastocysts. Resultant germline chimeric males (determined by the
transmission of coat colour in parallel breeding) were then crossed to C57BL/6
female homozygous Rosa26-FLPe mice (009086, Jackson Laboratories) in order to
excise the FRT-flanked lacZ gene trap from the Ube3aKO1st allele and thereby
produce the Ube3aFLOX allele. Ube3aFLOX mice were genotyped using the
following PCR primers: Ube3aFLOX F (50-AAAATTGGGTATGCGAGCTG-30) and
Ube3aFLOX R (50-GGGGTCTAAGGGCCTATGAA-30).
All mice were maintained on a congenic C57BL/6 background, had ad libitum
access to food and water, and were housed on a 12:12 light:dark cycle. Mice for
electrophysiological recordings were aged P60–P90 and were compared with wild-
type age- and sex-matched controls. The experimenter was blind to genotype, and
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Figure 5 | Exogenous VGAT expression in THCRE-positive neurons normalizes motivation and GABA co-release in THCRE::Ube3aFLOX/pþ mice.
(a) Schematic representation of the experimental paradigm. DIO-VGATand DIO-ChR2-eYFP were injected in experimental mice to selectively delete Ube3a
in TH-expressing neurons and to express exogenous ChR2 and VGAT in THþ VTA-to-NAc terminals. (b) Representative oIPSC evoked by single pulses
(20ms) or 30Hz trains of stimulation. (c) Average oIPSC peak amplitudes evoked by single pulses (n¼ 10 and 7, Student’s t-test P¼0.69), and
(d) average total charge evoked by 30Hz stimulation (n¼ 7 and 7, Student’s t-test P¼0.59) demonstrate that exogenous VGAT expression in THCRE
neurons normalizes GABA co-release between genotypes. (e) Response plots showing cumulative nose pokes that trigger a 30Hz, 473 nm stimulus (active
nose pokes) in representative mice. (f) Average nose pokes for inactive and active ports triggering 30Hz optical intracranial self-stimulation in a 60min
behavioural session (n¼ 6 and 6, one-way ANOVA P¼0.12). Bars represent mean±s.e.m.
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littermate controls were used when possible. Behavioural mice were group housed
until surgery, which was performed when mice weighed 25–30 g (BP60). Mice
were anesthetized with ketamine (150mg kg 1) and xylazine (50mg kg 1), and
then placed in a stereotaxic frame (Kopf Instruments) for bilateral injections
(0.5ml) of purified adeno-associated virus (B1012 viral genomesml 1, packaged
and titered by the UNC Viral Vector Core Facility) into the VTA (coordinates from
bregma:  3.15 anterior/posterior, ±0.75 medial/lateral,  4.75 dorsal/ventral).
VTA neurons in THCRE-positive Ube3am /pþ , Ube3aFLOX/pþ or Ube3aþ /þ mice
were transduced with virus encoding ChR2-eYFP and/or VGAT under the control
of the EF1a promoter. DIO-VGAT was generously provided by the laboratory of
Bernardo Sabatini15. Mice were individually housed following surgery. For
behavioural experiments, mice were implanted with bilateral chronic optical fibres
directed above the NAc (coordinates from bregma: þ 1.2 A/P, ±1.6 M/L,  4.6
D/V at a 10 angle). We performed all experiments 5–8 weeks post-surgery. All
procedures were conducted in accordance with the Guide for the Care and Use of
Laboratory Animals as adopted by the National Institutes of Health, and with
approval of the UNC Institutional Animal Care and Use committees.
Slice preparation for whole-cell electrophysiology and voltammetry. Mice
were anesthetized with pentobarbital (40mg kg 1) and intracardially perfused
with ice-cold dissection buffer (in mM: 87 NaCl, 2.5 KCl, 1.25 NaH2PO4, 26
NAHCO3, 75 sucrose, 10 dextrose, 1.3 ascorbic acid, 7 MgCl2 and 0.5 CaCl2)
bubbled with 95% O2–5% CO2 after disappearance of corneal reflexes. Brains were
then rapidly removed and immersed in ice-cold dissection buffer. VTA sections
were dissected and 200-mm thick horizontal slices were prepared using a vibrating
microtome (Leica VT1200S). NAc sections were dissected and 250-mm thick cor-
onal slices were prepared as described within the VTA. Slices recovered for 20min
in a 35 C submersion chamber filled with oxygenated artificial cerebrospinal fluid
(ACSF; in mM: 124 NaCl, 3 KCl, 1.25 NaH2PO4, 26 NAHCO3, 1 MgCl2, 2 CaCl2
and 20 glucose) and then kept at room temperature for 440min until use21.
Voltage-clamp recordings. To isolate sIPSCs (spontaneous inhibitory post-
synaptic currents), slices were placed in a submersion chamber, maintained at
27 C and perfused at 2mlmin 1 with oxygenated ACSF (as described above) and
held at the AMPAR reversal potential (þ 10mV). AMPAR reversal potential was
empirically determined by applying a series of 10 pA current injections ( 70 to
þ 60mV) in the presence of picrotoxin and D,L-APV. sIPSCs were confirmed post
hoc by the addition of 10 mM SR95531 (Abcam). Cells were visualized using a Zeiss
Examiner microscope equipped with infrared differential interference contrast
optics. Putative VTA-to-NAc dopaminergic neurons were identified by tdTomato
fluorescence medial to the medial terminal nucleus of the accessory optic tract in
THCRE::Ai9::Ube3am /pþ or wild-type mice. Patch pipettes were pulled from
thick-walled borosilicate glass (P2000, Sutter Instruments Novato, CA). Open-tip
resistances were between 2.5–5MO and were backfilled with an internal containing
(in mM): 100 CsCH3SO3, 15 CsCl, 2.5 MgCl2, 10 Hepes, 5 QX-314, 5 BAPTA, 4
Mg-ATP, 0.3 Mg-GTP and 0.025 Alexa-488 with pH adjusted to 7.25 with 1M
CsOH and osmolarity adjusted to B295mOsM by the addition of sucrose.
Voltage-clamp recordings were performed in the whole-cell configuration using a
patch-clamp amplifier (Multiclamp 700B, Molecular Devices), and data were
acquired and analysed using pClamp 10 software (Molecular Devices). Pipette seal
resistances were 41GO, and pipette capacitive transients were minimized before
breakthrough. Changes in series and input resistance were monitored throughout
the experiment by giving a test pulse every 30 s and measuring the amplitude of the
capacitive current. Cells were discarded if series resistance rose above 30MO.
Widefield ChR2-mediated photostimulation was provided through a  20/
0.8NA objective using single-photon excitation through a 470 nm l-filter. Light
power was provided by a Lambda DG-4 300W Xenon bulb (Sutter Instruments).
This light was coupled to a Mosaic microelectro-mechanical-system digital
micromirror device (Andor Technology) and was shuttered via pClamp-delivered
TTL pulse to the Lambda DG-4 as previously described22. Co-release from TH-
positive terminals originating in the VTA was measured in medium spiny neurons
in response to a single 20ms pulse as well as to a 1 s train of pulses at 30Hz
stimulation. Medium spiny neurons were identified by their shape and passive
membrane properties (Cm, Rm and decay constant) measured immediately after
break-in in the voltage-clamp configuration holding at  70mV.
Activation of ChR2-expressing fibres was performed by using square
illumination patterns (as described in ref. 22) in animals previously used in the
optical intracranial self-stimulation paradigm. In response to these stimuli, mean
E/IPSC amplitude, decay/rise tau and total charge were measured by averagingZ6
consecutive traces. Optical inhibitory/excitatory postsynaptic currents (oIPSCs/
oEPSCs) were measured in ventral striatum medium spiny neurons and were
selected by their membrane properties. oIPSCs were isolated by including DNQX
(20 mM, Abcam) and DL-APV (100 mM, Abcam) in the external solution, whereas
oEPSCs were isolated by including picrotoxin (50 mM, Sigma) in the external
solution. Patch pipette open-tip resistances were between 2.5–6MO and were
backfilled with (in mM): 125 CsCl, 10 TEA-Cl, 0.1 EGTA (CsOH), 10 Hepes, 3.3
QX-314, 1.8 MgCl2, 4 ATP, 0.3 GTP, 8 Na2-Phosphocreatine with pH adjusted to
7.25 with 1M CsOH and osmolarity adjusted to B295 by the addition of sucrose
for oIPSC experiments or with (in mM): 100 K-gluconate, 20 KCl, 10 Hepes, 0.2
EGTA, 4 ATP, 0.3 GTP, 10 Na2-Phosphocreatine with pH adjusted to 7.25 with
1M KOH and osmolarity adjusted to B295 by the addition of sucrose for oEPSC
experiments. The high internal-chloride concentration increased the chloride-
driving force and allowed for oIPSCs to be more easily resolved at  70mV.
Changes in series and input resistance were monitored throughout the experiment
and did not differ between genotypes (P40.05). Recordings were discarded if series
resistance rose above 30MO.
For validation of VMAT2-mediated GABA co-release from THþ neurons,
mice were injected intraperitoneally 24 h before killing with reserpine (5mg kg 1,
Tocris 2742). Mice were then killed if they displayed ptosis and paralysis the
following day. Slices of ventral striatum were prepared as described above.
Reserpine was also included within the slice recovery chamber (1 mM), and slices
were constantly incubated in reserpine before recording. Recordings of GABA
co-release were performed as described above.
Current-clamp recordings. Intrinsic excitability experiments were performed at
 50 to  60mV in ACSF containing picrotoxin (50 mM, Sigma), DNQX (20 mM,
Abcam) and DL-APV (100 mM, Abcam) to block excitatory and inhibitory
transmission. Putative VTA-to-NAc dopaminergic cells were selected as described
above and pipettes were backfilled with (in mM): 100K-gluconate, 20 KCl, 10
Hepes, 0.2 EGTA, 4 ATP, 0.3 GTP, 10 Na2-Phosphocreatine and 0.015 Alexa-488
(Life Technologies) with pH adjusted to 7.25 with 1M KOH and osmolarity
adjusted toB295 by the addition of sucrose. For frequency–current plots, current
was injected at 40 pA steps and average action potential frequency was calculated.
Peak amplitude was calculated by averaging the max amplitude for all events across
all collected traces. Maximum instantaneous frequency was calculated by taking the
inverse of the shortest inter-event interval across all collected traces. Changes in
series and input resistance were monitored throughout the experiment by giving a
test pulse every 30 s and measuring the amplitude of the capacitive current. Cells
were discarded if series resistance rose above 30MO.
Fast-scan cyclic voltammetry. Ventral striatum sections were prepared as
described above. Electrochemical data were acquired using a custom-written
software in LabVIEW (Tar Heel CV) and filtered offline at 1 kHz. Briefly, carbon-
fibre microelectrodes (50mM in length) were scanned from  0.4 V to 1.3 V at a
rate of 400V s 1. Samples were acquired at a rate of 10Hz. Light pulses (5ms,
473 nm, 1mW) were delivered through a  40 objective via a high-powered LED
(Thorlabs) to evoke dopamine release. A single pulse or 5 light pulses were
delivered at 1, 5, 10, 20, 30 or 40Hz in a randomized order. Immediately after
optical stimulation of the slice, background-subtracted cyclic voltammograms were
generated, which were characteristic of dopamine (peak oxidation potential of
600–700mV).
Immunohistochemistry. Mice were anesthetized with pentobarbital and then
perfused with 4% paraformaldehyde in phosphate-buffered saline (PBS; pHB7.3).
Samples were placed in 10, 20 and then 30% sucrose in PBS before being cut at
40 mm using a cryostat (Leica). Sections were collected, rinsed (PBS) and blocked
with 5% normal goat serum and 0.2% Triton X-100 in PBS. Sections were then
tumbled in this blocking solution with primary antibody for 24 h at 4 C. The
primary antibodies used in this study were rabbit anti-TH (1:650 Millipore,
AB152), chicken anti-EGFP (1:1,000 Aves) and mouse anti-UBE3A (1:750 Sigma
clone 3E5, SAB1404508). Transgenic fluorescent proteins expressed via CRE-
mediated recombination (Ai9 mice) were not further antibody enhanced. Sec-
ondary detection was performed with Alexa Fluor 488, 568 or 633 conjugated goat
anti-rabbit, anti-chicken or anti-mouse antibodies (Invitrogen). Mounted sections
were imaged on a Zeiss LSM 710 Confocal Microscope using  20/0.8 or  40/
1.3 NA objectives. Immunohistochemistry was used to validate viral injection, fibre
placement and recombination efficiency post hoc in experimental animals.
Fluorescence in situ hybridization. Mice were rapidly decapitated after 2 weeks
post-operationally and brains were snap frozen in dry ice in O.C.T. Compound
(Fisher Scientific). Fresh, frozen brains were sectioned at 20 mm on a cryostat
(CM1950, Leica) onto charged slides (Leica). Samples were hybridized to GAD1
antisense or sense riboprobes. A 950-bp riboprobe complementary to GAD1-sense
cDNA was inserted into the pcrII-TOPO vector (Life Technologies). Plasmid DNA
was then digested with EcoRV or Asp718 in order to create sense and antisense
template for in vitro transcription. All probes were created using florescein-labelled
nucleotides for detection. EcoRV template was transcribed with Sp6 RNA
polymerase for the generation of the sense riboprobe and Asp718 template was
transcribed with T7 RNA polymerase for the generation of the antisense riboprobe.
Fluorescence in situ hybridization was performed at room temperature unless
otherwise specified. Tissue was dried at 50 C, fixed in 4% DEPC-PFA for 15min
and washed in DEPC-PBS three times for 5min. The tissue was then acetylated in
1 triethanolamine-HCl with 0.25% acetic anhydride for 10min and subsequently
washed in DEPC-PBS 3 times for 5min each. Next, the tissue was pre-hybridized
for 3 h at 65 C in hybridization buffer containing 5 saline sodium citrate (SSC),
50% formamide, 1mgml 1 yeast tRNA, 0.1mgml 1 heparin, 0.1% tween-20,
0.005M EDTA (pH 8.0) and 0.1% CHAPS. Subsequently, the tissue was incubated
in hybridization buffer containing a probe for GAD1 (fluorescein-labelled).
Post-hybridization stringency washes were performed sequentially at 65 C in
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pre-warmed buffers: 1 15min in 2 SSC and 3 20min in 0.2 SSC buffer.
After the stringency washes, tissue was washed additionally at room temperature
2 10min in TS7.5 (0.1M Tris-HCl, pH 7.5, 0.15M NaCl). Tissue was then
incubated in 3% H2O2 in methanol and washed 3 5min in TS7.5 to quench
endogenous hydrogen peroxidase activity. Sections were then incubated for 1 h in
1% blocking buffer (Perkin Elmer), followed by incubation for 24 h at 4 C in anti-
Fluorescein-POD (1:350). Then, sections were washed 3 10min in TNT wash
buffer (0.1M Tris-HCl (pH 7.5), 0.15M NaCl, 0.05% Tween-20), sections under-
went a tyramide signal amplification with TSA plus TM POD-DNP (Perkin Elmer,
NEL747B) 1:50 in amplification diluent. Following a 4–7min incubation, sections
were washed with TNT wash buffer 4 10min and incubated in a DNP primary
antibody conjugated to Alexa Fluor 488 (1:500, Molecular Probes) at 3 h at room
temperature. Sections were then washed 3 10min in PBS and coverslipped with a
mounting media containing DAPI (Life Technologies).
In vivo optogenetic stimulation. For all behavioural experiments, mice were
injected with AAV5-EF1a-DIO-ChR2-eYFP and/or AAV8-EF1a-DIO-VGAT (at a
1:1 ratio) virus and implanted with bilateral custom-made optical fibre targeted to
the NAc core23. Mice were connected to a ‘dummy’ optical patch cable 5 days
before the experiment each day for 60min to habituate them to the tether
procedure. Following the tethering procedure, we ran the mice in several
behavioural procedures (detailed below). We used a 10mW, 473 nm laser with a
stimulation frequency of 30Hz and a 5ms pulse width duration for all behavioural
assays unless otherwise noted.
Positive-reinforcement procedures and optical self-stimulation. Behavioural
training and testing occurred in mouse operant chambers (Med Associates)
interfaced with optogenetic stimulation equipment. Behavioural paradigms were
performed during their respective dark cycle. Food-restricted male mice (90% of
their free-feeding bodyweight) were trained on a fixed-ratio (1:1) training schedule
for one session per day for 60min, in which each nose-poke resulted in 20 ml of a
15% sucrose administration until the number of nose pokes did not vary 420%
across 3 consecutive days. In addition, active nose-poke ports were coupled with a
cue light that remained on. With each successful nose-poke, the cue light turned off
and a tone would be presented for 3 s. Once the mice reached a stable number of
nose pokes, they were habituated for 5 consecutive days to the patch cable with
optical stimulation (3 s of 30Hz) time-locked to the cue following each active nose-
poke. After the 5-day habituation phase, mice were then tested following a 2-day
break. Active and inactive nose pokes were recorded in addition to time-stamps.
Statistics and data analysis. We plotted all data and performed all statistical
analyses using GraphPad Prism software. All graphs are represented as the
mean±s.e.m. For statistical analyses, we used two-way analysis of variance
(Figs 1d, 2c and 4a), one-way analysis of variance (Figs 2c and 3c) or two-tailed
Student’s t-test (Figs 2b, 3, 4f–h and 5c,d, Supplementary Figs 2b, 3a, 4b,c and
5b,c). Statistical significance is represented as follows: *Po0.05, **Po0.02 and
***Po0.001. Minimum sample sizes were estimated from previously published
data sets with similar experimental parameters. The only data points that were
discarded were done so before unblinding and only because the data points did not
meet a priori criteria for data inclusion (for example, series resistance in a whole-
cell recording was above our established limit for inclusion). No outlier test was
used to discount any data point, and all data points are included within the
summarized graphs.
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